Journal article icon

Journal article

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.

Abstract:

BACKGROUND AND OBJECTIVE: Two long-acting depot somatostatin analogues have recently been licensed for the treatment of acromegaly. We wished to assess the effectiveness of both these drugs in suppressing mean GH to a target of < 5 mU/l in patients with acromegaly unselected for responsiveness to octreotide, and also to compare the effects of both drugs METHODS: We prospectively studied 10 unselected patients with acromegaly who were treated first with lanreotide (LAN) and then octreotide ...

Expand abstract

Actions


Access Document


Authors


Turner, HE More by this author
Vadivale, A More by this author
Journal:
Clinical endocrinology
Volume:
51
Issue:
3
Pages:
275-280
Publication date:
1999-09-05
DOI:
EISSN:
1365-2265
ISSN:
0300-0664
URN:
uuid:fc568980-978a-4e96-bf4e-c21d48b74404
Source identifiers:
8541
Local pid:
pubs:8541

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP